On this page
Aida Levitan
Insider
First SEC filing: Oct. 9, 2025 · Latest: Oct. 9, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 8, 2025 | USCB | G | 10,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 12, 2025 | USCB | M | 7,500 | $7.50 | $56,250 | 7,500 Direct | · | Acquired | 200.7% (price as of 2026-10-02) |
| Sept. 12, 2025 | USCB | M | 2,500 | $7.50 | $18,750 | 10,000 Direct | +33.33% | Acquired | 200.7% (price as of 2026-10-02) |
| Sept. 12, 2025 | USCB | M | 7,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 12, 2025 | USCB | M | 2,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 13, 2023 | USCB | D | 250 | $12.08 | $3,020 | 14,968 Indirect | +1.70% | Acquired | 86.7% (price as of 2026-10-02) |
| Feb. 10, 2023 | USCB | D | 250 | $12.30 | $3,075 | 14,718 Indirect | +1.73% | Acquired | 83.3% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 12, 2025 | USCB | Stock Option (Right to Buy) | Common Stock | $7.50 | March 22, 2026 | 7,500 | Disposed |
| Sept. 12, 2025 | USCB | Stock Option (Right to Buy) | Common Stock | $7.50 | July 23, 2028 | 2,500 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).